NPPA notified regarding the computation of the retail price of Telmisartan I.P. 40 mg + Chlorthalidone IP 12.5 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

Mar 17, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 17, 2025, notified regarding the computation of the retail price of Telmisartan I.P. 40 mg + Chlorthalidone IP 12.5 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer)

It states that the price of each 5 ml of reconstituted Suspension containing:- Telmisartan I.P. 40 mg + Chlorthalidone IP 12.5 mg + Metoprolol Succinate I.P. 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s. Alembic Pharmaceuticals Ltd. (Marketer) has been revised to Rs. 11.30/-.


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT